Activity of novel plant extracts against medullary thyroid carcinoma cells. Anticancer Res

Universität Heidelberg, Heidelburg, Baden-Württemberg, Germany
Anticancer research (Impact Factor: 1.83). 03/2004; 24(2A):495-500.
Source: PubMed


Medullary thyroid carcinoma (MTC) is a rare calcitonin-producing tumor, derived from the parafollicular C-cells of the thyroid. MTC is known to be relatively insensitive to conventional chemotherapy.
Eight cell lines were established from MTCs; each showed an up-regulation of Bcl-2. We investigated ten agents from plants of the genera Stemona (Stemonaceae), Aglaia (Meliaceae) and Artemisia (Asteraceae) for their effects on proliferation and apoptotic rates. Extracts have been used in traditional Chinese medicine; however, no experience on their effects on medullary thyroid carcinomas has been reported so far. Growth kinetics and viability were examined using the Casy-1-Cell Counter & Analyzer and the WST-1-based cytotoxicity assay. Apoptosis was studied by DAPI staining, by measurement of caspase-3 activity and Bcl-2 expression.
A strong antiproliferative effect was recognized in each Aglaia species and with Artesunate, whereas an enhancement of apoptosis was provoked particularly by Stemona tuberosa Lour.
The activity of the novel plant extracts possiby offers a new approach towards successful chemotherapy of the so far chemo-resistant medullary thyroid carcinoma.

Download full-text


Available from: Thomas Efferth, Dec 29, 2015
  • Source
    • "This pathway plays a major role in drug-induced apoptosis (Schmitt et al 2000) whereas we found here that caspase 9 was not activated by ST-2. Together with our previous study (Rinner et al 2004) in which the expression of the antiapoptotic protein bcl-2 was not found to have changed by total ST-extracts, we assume Figure 5 ST-2 infl uenced the MTC-SK aggregation and morphology. (A) Cellular morphology. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Medullary thyroid carcinoma (MTC), a neuroendocrine tumor arising from the thyroid gland, is known to be poorly responsive to conventional chemotherapy. The root of Stemona tuberosa Lour, also called Bai Bu, is a commonly used traditional Chinese anti-tussive medicine. The present study investigated this medicinal herb for the first time with respect to its anticancer activity in human medullary thyroid carcinoma cells. Four extracts of Stemona tuberosa Lour, including the n-hexane fraction, (ST-1), dichloromethane (DCM) fraction, (ST-2), ethyl acetate (EtOAc) fraction, (ST-3), and methanol fraction, (ST-4) were examined for antiproliferative effects in two MTC cell lines. We observed that only the DCM fraction ST-2 inhibited cell growth and viability in a dose-dependent manner. Furthermore, we found that ST-2 also induced the apoptosis of MTC-SK cells. Caspase-3/7 was activated, while caspase-9 was not, implying that at least a caspase-dependent apoptotic pathway was involved in this process. In addition, the multicellular spheroids of MTC-SK were destroyed and the cell morphology was changed by ST-2. Our results show the strong apoptotic effects of the DCM fraction of Stemona tuberosa Lour on human medullary thyroid carcinomas, so suggesting a new candidate for chemotherapy of the so far chemo-resistant medullary thyroid carcinoma.
    Full-text · Article · Jan 2008 · Targets & therapy
  • Source
    • "Intermediate IC 50 values were obtained for melanomas, breast, ovarian, prostate, CNS, and renal cancer cell lines (Efferth et al., 2001). Artesunate also inhibited the growth of medullary thyroid carcinoma cells (Rinner et al., 2004). The IC 50 values for artesunate correlated significantly with the cell doubling times and the portion of cells in the G0/G1 or S cell cycle phases of the NCI cell lines (Efferth et al., 2003a). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In addition to their well-known anti-malarial activity, artemisinin and its derivatives (1,2,4-trioxanes) possess potent activity against tumor cells in the nano- to micromolar range. Candidate genes that may contribute to the sensitivity and resistance of tumor cells to artemisinins were identified by pharmacogenomic and molecular pharmacological approaches. Target validation was performed using cell lines transfected with candidate genes or corresponding knockout cells. These genes are from classes with different biological function; for example, regulation of proliferation (BUB3, cyclins, CDC25A), angiogenesis (vascular endothelial growth factor and its receptor, matrix metalloproteinase-9, angiostatin, thrombospondin-1) or apoptosis (BCL-2, BAX). Artesunate triggers apoptosis both by p53-dependent and -independent pathways. Anti-oxidant stress genes (thioredoxin, catalase, gamma-glutamyl-cysteine synthetase, glutathione S-transferases) as well as the epidermal growth factor receptor confer resistance to artesunate. Cell lines over-expressing genes that confer resistance to established anti-tumor drugs (MDR1, MRP1, BCRP, dihydrofolate reductase, ribonucleotide reductase) were not cross-resistant to artesunate, indicating that this drug has a different target and is not subject to multidrug resistance. The Plasmodium translationally controlled tumor protein (TCTP) represents a known target protein of artemisinin and its derivatives in the malaria parasite. The microarray-based mRNA expression of human TCTP correlated with sensitivity to artesunate in tumor cells, suggesting that human TCTP contributes to response of tumor cells to the drug. The multi-factorial nature of cellular response to artemisinin and its derivatives may be beneficial to treat otherwise drug-resistant tumors and may explain why resistance development has not been observed in either cancer or malaria.
    Full-text · Article · Feb 2005 · Drug Resistance Updates
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The roots of Stemona (Stemonaceae) have long been used traditionally for the treatment of respiratory diseases, enteric helminthes and as insecticides. In the present study, the dichloromethane-methanol (DCM-M, 1:1), 95% ethanol and aqueous extracts of Stemona collinsae roots were investigated for in vitro antimicrobial, antiviral and anticancer activities. Using a plaque reduction assay, the DCM-M extract showed moderate activity against herpes simplex virus (HSV) type 1 and type 2 with 50% inhibitory concentrations of 105 ± 3.5 and 107 ± 6.2 µg/ml, respectively. Ethanol and aqueous extracts minimally inhibited HSV even at 300 µg/ml. All extracts exerted antiproliferative activity against malignant cell lines KB and MCF-7, with 50% cytotoxic concentrations ranging from 85 to 270 µg/ml. For anti-hepatitis B study, none were active against HBsAg secretion. Using a disc diffusion assay, all extracts displayed no activity against Staphylococcus aureus, Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger.
    Full-text · Article ·
Show more